The HCPLive Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.
October 8th 2024
An interim analysis of the PRO-SPIRIT study compared outcomes at 3 months after starting new treatments for psoriatic arthritis.
Collaborating Across the Continuum™: The Role of Multidisciplinary Care in the Management of Patients with Exocrine Pancreatic Insufficiency
View More
Cases and Conversations™: Applying Best Practices to Prevent Shingles in Your Practice
October 16, 2024
Register Now!
Tackling Inequities in IBD: Inclusive Solutions for Elevated Patient Care
October 26, 2024
Register Now!
6th Annual Advanced Practice Collaborative
View More
SimulatED™: Personalizing Treatment Choices to Achieve Glycemic and Weight Management Goals
View More
Cases and Conversations™: Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis
November 18, 2024
Register Now!
Shaping the Management of COPD with Biologic Therapy
View More
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Expert Illustrations & Commentaries™: Exploring the Role of Novel Agents for the Management of IgA Nephropathy
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical ShowCase™: Finding the Best Path Forward for Patients with COPD
View More
A Tethered Approach to Type 2 Diabetes Care – Connecting Insulin Regimens with Digital Technology
View More
Surv.AI Says™: What Clinicians and Patients Are Saying About Glucose Management in the Technology Age
View More
Clinical ShowCase™: Forming a Personalized Treatment Plan for a Patient With ANCA-Associated Vasculitis
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
SimulatED™: Diagnosing and Treating Alzheimer’s Disease in the Modern Era
View More
Patient, Provider & Caregiver Connection™: Implementing an Effective Management Plan to Improve Outcomes in IgA Nephropathy
View More
Cardiovascular Disease in Postmenopausal Women with Metabolic Syndrome
September 26th 2019Postmenopausal women with early rheumatoid arthritis have a metabolic syndrome profile similar to men and should equally be considered high risk for the development of cardiovascular disease, according to Bindee Kuriya M.D, writing in the journal ACR Open Rheumatology.
13 Tips to Improve Patient Encounters
September 26th 2019Patient visits can be highly complex and stressful for both patient and physician, but good manners can make the difference between a successful visit and a poor one. In this slideshow, we highlight 13 tips that may lead to better patient encounters.
You’re Not as Good as You Think (at Communicating)
September 25th 2019The quality of doctor-patient communications varies, says Susmita Pati, M.D. “In general, many people feel that many physicians don't communicate very well. On the other hand, there are plenty of folks who feel they have done really great.”
Paying for Rheumatology Care is Complex
September 25th 2019The price of a medication can be a significant factor in poor adherence to treatment, and few other specialties have higher medication prices than rheumatology. How can rheumatologists help their patients navigate the system so that they can get the best medication at the best price?
PSA Quiz: Joint Symptoms and New Treatments
September 25th 2019In today's installment of our psoriatic arthritis quiz, we revisit some recently published studies and news headlines. What new treatment for psoriatic arthritis has gone before the FDA for approval? Test your knowledge on this and other recent headlines in this quiz.
Alendronate Shows Promise as Maintenance Therapy for Osteoporosis
September 24th 2019The bisphosphonate alendronate (Binosto and Fosamax) can effectively maintain the gains in bone mineral density achieved with a year-long course of denosumab treatment in 91 percent of 126 patients who participated in a randomized clinical trial presented this week at the American Society for Bone and Mineral Research annual meeting in Orlando.
Warfarin May Heighten Risk of Osteoporosis in Afib Patients
September 24th 2019Patients with atrial fibrillation are commonly prescribed oral anticoagulants for stroke prevention, but in older patients at risk for osteoporosis, treatment with blood thinners may heighten osteoporosis risk, according to a study presented this week at the American Society for Bone and Mineral Research annual meeting in Orlando.
Calcium Supplementation Doesn't Improve or Hurt Cardiovascular Health
September 23rd 2019Taking calcium supplements doesn't appear to worsen cardiovascular health in healthy postmenopausal women, according to a study presented at the American Society for Bone and Mineral Research annual meeting that took place over the weekend.
New Osteoporosis Guidelines Support Multi-Disciplinary Treatment
September 23rd 2019Bone fracture patients should be managed by a multi-disciplinary clinical team that includes case management to ensure that patients are being properly and fully evaluated and treated for osteoporosis and the risk of future fractures, according to clinical recommendations issued on Friday by the a international group of experts speaking at the annual American Society for Bone and Mineral Research (ASBMR) meeting that took place over the weekend in Orlando.
First-Ever Treatment for Lupus Nephritis Wins FDA Breakthrough Status
September 20th 2019Roche announced this week that the U.S. Food and Drug Administration granted breakthrough therapy designation of obinutuzumab (Gazyva) for lupus nephritis, a major morbidity of systemic lupus erythematosus (SLE).
9 Lupus Nephritis Studies that Should be on Your Radar
September 20th 2019Investigators are currently pursuing at least 50 possible new treatments, or treatment targets, for systemic lupus and lupus nephritis. We're tracking the studies and in this slideshow, we highlight the results from nine new studies on lupus nephritis.
New Treatment Option for Systemic Sclerosis-Associated Interstitial Lung Disease
September 19th 2019The U.S. Food and Drug Administration has approved nintedanib (Ofev, Boehringer Ingelheim Pharmaceuticals) capsules to slow the rate of decline in pulmonary function in adults with systemic sclerosis-associated interstitial lung disease (SSc-ILD), which is a progressive lung disease that can be debilitating and life-threatening.
Knee Osteoarthritis Pain Intensity is Gender-Related
September 19th 2019Levels of the biomarker urine C-telopeptide of cross-linked collagen type II (uCTX-II) are independently associated with radiographic severity and pain intensity in knee osteoarthritis, say researchers writing in Arthritis Research & Therapy this month.
Step Therapy in Rheumatology is Most Common in Southern States, ACR Survey Shows
September 18th 2019ACR has released the results of a new patient survey that shows one in four patients live with rheumatic disease and although most have health insurance, they still have substantial out of pocket costs. The survey shows that many patents have difficulty getting prescribed medications due to step therapy, a controversial health insurance program that requires patients to use the most cost-effective drug therapy instead of the therapy recommended by their physician.
10 Most Cited Studies from the Journal Rheumatology Begins with Lupus
September 18th 2019Rheumatology, the journal of the British Society for Rheumatology, is offering free access (through December 31) to its ten most highly cited papers of 2017 and 2018. In this slideshow, we highlight the 10 most cited articles.
NSAIDs May Increase Cardiovascular Disease Risk in Osteoarthritis
September 16th 2019Nonsteroidal anti-inflammatory drug (NSAID) use contributes substantially to the increased risk of cardiovascular disease among patients with osteoarthritis, say researchers writing in Arthritis & Rheumatology last month.
OK to Withdraw Methotrexate Post Tofacitinib Combo Treatment
September 16th 2019Rheumatoid arthritis patients who achieve low disease activity on tofacitinib in combination with methotrexate, should be able to discontinue methotrexate safely and without significant worsening of disease activity, especially if they are having trouble tolerating it, new research shows.